I believe Inovio Pharmaceuticals’ upside rests almost entirely on INO-3107. The FDA set a standard-review PDUFA for October 30, 2026. INO-3107 targets HPV-6/11 RRP, aiming to reduce repeat surgeries ...
Disney is celebrating love Star Wars-style with a new and adorable set of Star Wars Droid Factory astromech figures. Say hello to R2-LVU and R2-INO, two poseable droids that are decked out in pink and ...
Hosted on MSN
FDA accepts Inovio’s BLA for INO-3107 review
Inovio Pharmaceuticals ( (INO)) has provided an announcement. On December 29, 2025, INOVIO announced that the U.S. Food and Drug Administration accepted for review its Biologics License Application ...
Some members of the maker community are distraught about Arduino’s new terms of service (ToS), saying that the added rules put the company’s open source DNA at ...
Forbes contributors publish independent expert analyses and insights. Chief Analyst & CEO, NAND Research. Qualcomm, a company built on selling chips to companies like Samsung and Apple in volumes of ...
Qualcomm's acquisition gives it access to millions of developers in the Arduino ecosystem while also supporting its platform strategy for embedded devices, which now extends across hardware, software, ...
Qualcomm announced Tuesday it will acquire Arduino for undisclosed terms. The chipmaker said the Italy-based company would become an independent subsidiary of Qualcomm. In this article Qualcomm wants ...
Smartphone processor and modem maker Qualcomm is acquiring Arduino, the Italian company known mainly for its open source ecosystem of microcontrollers and the software that makes them function. In its ...
In order to make it easier for beginners to get started with writing Arduino sketches, and for the convenience of all users, Arduino CLI automatically generates and adds prototypes for functions ...
Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday’s session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses. See the ...
Inovio Pharmaceuticals Inc (NASDAQ:INO) shares are trading lower by 40% to $2.23 during Friday’s session after the company priced a public offering of 10 million shares of common stock and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results